CGNSF (Cognetivity Neurosciences) Interest Expense : $-3.38 Mil (TTM As of Oct. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cognetivity Neurosciences's interest expense for the three months ended in Oct. 2023 was $ -0.97 Mil. Its interest expense for the trailing twelve months (TTM) ended in Oct. 2023 was $-3.38 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cognetivity Neurosciences's Operating Income for the three months ended in Oct. 2023 was $ -0.65 Mil. Cognetivity Neurosciences's Interest Expense for the three months ended in Oct. 2023 was $ -0.97 Mil. Cognetivity Neurosciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cognetivity Neurosciences Interest Expense Historical Data

The historical data trend for Cognetivity Neurosciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Interest Expense Chart

Cognetivity Neurosciences Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Interest Expense

Get a 7-Day Free Trial

0.02

-0.04

-0.05

-0.77

Cognetivity Neurosciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Interest Expense	Get a 7-Day Free Trial															-0.05	-0.68	-0.84	-0.89	-0.97

Cognetivity Neurosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.38 Mil.

Cognetivity Neurosciences (OTCPK:CGNSF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cognetivity Neurosciences's Interest Expense for the three months ended in Oct. 2023 was $-0.97 Mil. Its Operating Income for the three months ended in Oct. 2023 was $-0.65 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Oct. 2023 was $1.00 Mil.

Cognetivity Neurosciences's Interest Coverage for the quarter that ended in Oct. 2023 is calculated as

Cognetivity Neurosciences did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Cognetivity Neurosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

1UB:Germany CGN:Canada

Address

800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6

Website

https://www.cognetivity.com

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences Headlines

From GuruFocus

Three Companies Using AI and Innovation to Lead Healthcare Sector

By ACCESSWIRE AccessWire • 04-12-2019

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire • 04-12-2019